Detalles de la búsqueda
1.
The implementation of a noninvasive lymph node staging (NILS) preoperative prediction model is cost effective in primary breast cancer.
Breast Cancer Res Treat
; 194(3): 577-586, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-35790694
2.
Intraductal papillary mucinous neoplasms of the pancreas - a cost-effectiveness analysis of management strategies for the branch-duct subtype.
HPB (Oxford)
; 20(12): 1206-1214, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30064727
3.
MRI-only radiotherapy from an economic perspective: Can new techniques in prostate cancer treatment be cost saving?
Clin Transl Radiat Oncol
; 38: 183-187, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36479236
4.
Cost-Effectiveness of Once-Weekly Semaglutide 1 mg versus Canagliflozin 300 mg in Patients with Type 2 Diabetes Mellitus in a Canadian Setting.
Appl Health Econ Health Policy
; 20(4): 543-555, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35344191
5.
Long-Term Cost Effectiveness of Oral Semaglutide Versus Empagliflozin and Sitagliptin for the Treatment of Type 2 Diabetes in the Swedish Setting.
Pharmacoecon Open
; 6(3): 343-354, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35064550
6.
The Value of a New Diagnostic Test for Prostate Cancer: A Cost-Utility Analysis in Early Stage of Development.
Pharmacoecon Open
; 5(1): 77-88, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-32780268
7.
Comparing the Cohort and Micro-Simulation Modeling Approaches in Cost-Effectiveness Modeling of Type 2 Diabetes Mellitus: A Case Study of the IHE Diabetes Cohort Model and the Economics and Health Outcomes Model of T2DM.
Pharmacoeconomics
; 38(9): 953-969, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32399797
8.
Cost-effectiveness of once-weekly semaglutide versus dulaglutide and lixisenatide in patients with type 2 diabetes with inadequate glycemic control in Sweden.
J Med Econ
; 22(10): 997-1005, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31044636
9.
Cost-effectiveness of liraglutide versus lixisenatide as add-on therapies to basal insulin in type 2 diabetes.
PLoS One
; 13(2): e0191953, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29408938
10.
Correction to: Cost-Effectiveness of Once-Weekly Semaglutide 1 mg versus Canaglifozin 300 mg in Patients with Type 2 Diabetes Mellitus in a Canadian Setting.
Appl Health Econ Health Policy
; 20(4): 623, 2022 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-35441978
Resultados
1 -
10
de 10
1
Próxima >
>>